Metabolic markers including fasting insulin, triglycerides, and liver enzymes often improve in parallel with the fat loss
We randomly divided the successfully modeled PCOS mice into three groups: PCOS group (PCOS, n=6), PCOS+semaglutide 0.42 mg/kg/w group (S-Low, n=6), and PCOS+semaglutide 0.84 mg/kg/w group (S-High, n=6)
If your Current Weight is: Your new weight could be: Average study participant lost 15% *In the STEP 5 trial, participants for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes, patients taking semaglutide (typically in doses of 2.4 mg once weekly) for weight management lost an average of about 15% of their body weight over 68 weeks
AOD-9604 inhibits lipogenesis while promoting fat breakdown
For current shipping status by state, check the real-time map on our homepage